Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial

• Main Authors: Kei Nakashima (Author), Masahiro Aoshima (Author), Satoko Ohfuji (Author), Satoshi Yamawaki (Author), Masahiro Nemoto (Author), Shinya Hasegawa (Author), Satoshi Noma (Author), Masafumi Misawa (Author), Naoto Hosokawa (Author), Makito Yaegashi (Author), Yoshihito Otsuka (Author)
• Format: Book
• Published: Taylor & Francis Group, 2018-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

It is unclear whether simultaneous administration of a 23-valent pneumococcal polysaccharide vaccine (PPSV23) and a quadrivalent influenza vaccine (QIV) produces immunogenicity in older individuals. This study tested the hypothesis that the pneumococcal antibody response elicited by simultaneous adm...